Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Concurrent Chemoradiotherapy vs Chemotherapy Alone in Completely Resected Microscopic N2 NSCLC
NCT01066234Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Oct 2017
- Primary completion
- Jan 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, cisplatin, carboplatin in non-small cell lung cancer (NSCLC), sponsored by Samsung Medical Center. Started Oct 2017; status: completed.
02
Drugs
paclitaxelcisplatincarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01066234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066234.